TY - JOUR
T1 - Modeling the functional impact of CPEB3 and CPEB4 dysregulation in autism
T2 - A theoretical–computational framework
AU - González-Paz, Lenin
AU - Vivas, Alejandro
AU - Cardozo-Urdaneta, Arlene
AU - Lossada, Carla
AU - Mendez, Anibal
AU - Delgado, Ariana
AU - Marrero-Ponce, Yovani
AU - Martinez-Rios, Felix
AU - Pérez-Castillo, Yunierkis
AU - Alvarado, Ysaías J.
N1 - Publisher Copyright:
© 2026 Elsevier Inc.
PY - 2026/3
Y1 - 2026/3
N2 - Autism spectrum disorder (ASD) involves impaired synaptic plasticity tightly coupled to local mRNA translation. Cytoplasmic polyadenylation element-binding proteins 3 and 4 (CPEB3 and CPEB4) are post-transcriptional regulators of neuronal mRNA translation that may contribute to ASD-related molecular alterations. In this theoretical–computational study, we develop a weighted functional impact model that integrates transcriptomic expression with intrinsic molecular constraints of CPEB3 and CPEB4 to estimate regional and cell type–specific vulnerability in ASD. Coarse-grained molecular dynamics (MD) simulations were quantitatively analyzed to assess aggregation, diffusion, and cluster stability under cell type–specific cytoplasmic conditions, with statistical uncertainty explicitly evaluated. The anterior cingulate cortex and thalamus emerged as primary vulnerability sites. Despite higher CPEB4 expression—mainly in glial cells—our weighted functional impact model predicted greater theoretical susceptibility linked to CPEB3 dysfunction, particularly in inhibitory and excitatory neurons. MD simulations revealed that CPEB3 forms transient diffusion-permissive aggregates, whereas CPEB4 tends to assemble into more stable condensates. These complementary behaviors suggest differential but interdependent regulation of neuronal and glial functions. Importantly, the proposed framework provides experimentally testable predictions on how protein–protein interactions, microexon loss, and cytoplasmic crowding influence translational control in ASD. This integrative approach provides a quantitative and biologically grounded framework to investigate how post-transcriptional regulators contribute to ASD-relevant molecular vulnerability.
AB - Autism spectrum disorder (ASD) involves impaired synaptic plasticity tightly coupled to local mRNA translation. Cytoplasmic polyadenylation element-binding proteins 3 and 4 (CPEB3 and CPEB4) are post-transcriptional regulators of neuronal mRNA translation that may contribute to ASD-related molecular alterations. In this theoretical–computational study, we develop a weighted functional impact model that integrates transcriptomic expression with intrinsic molecular constraints of CPEB3 and CPEB4 to estimate regional and cell type–specific vulnerability in ASD. Coarse-grained molecular dynamics (MD) simulations were quantitatively analyzed to assess aggregation, diffusion, and cluster stability under cell type–specific cytoplasmic conditions, with statistical uncertainty explicitly evaluated. The anterior cingulate cortex and thalamus emerged as primary vulnerability sites. Despite higher CPEB4 expression—mainly in glial cells—our weighted functional impact model predicted greater theoretical susceptibility linked to CPEB3 dysfunction, particularly in inhibitory and excitatory neurons. MD simulations revealed that CPEB3 forms transient diffusion-permissive aggregates, whereas CPEB4 tends to assemble into more stable condensates. These complementary behaviors suggest differential but interdependent regulation of neuronal and glial functions. Importantly, the proposed framework provides experimentally testable predictions on how protein–protein interactions, microexon loss, and cytoplasmic crowding influence translational control in ASD. This integrative approach provides a quantitative and biologically grounded framework to investigate how post-transcriptional regulators contribute to ASD-relevant molecular vulnerability.
KW - Autism
KW - Brain expression patterns
KW - CPEB3
KW - CPEB4
KW - Post-transcriptional regulation
UR - https://www.scopus.com/pages/publications/105028990169
U2 - 10.1016/j.mcn.2026.104072
DO - 10.1016/j.mcn.2026.104072
M3 - Artículo
C2 - 41581680
AN - SCOPUS:105028990169
SN - 1044-7431
VL - 136
JO - Molecular and Cellular Neuroscience
JF - Molecular and Cellular Neuroscience
M1 - 104072
ER -